Lena M Carlsson

Title: Lena M Carlsson: Innovator in Growth Hormone Research

Introduction

Lena M Carlsson is a prominent inventor based in Goteborg, Sweden. She has made significant contributions to the field of growth hormone research, holding a total of 4 patents. Her work focuses on innovative methods for treating partial growth hormone insensitivity syndrome, which has important implications for patient care.

Latest Patents

Lena's latest patents describe methods for increasing the growth rate of human patients suffering from partial growth hormone insensitivity syndrome, excluding those with Laron syndrome. One method involves administering an effective dose of growth hormone, preferably with a native human sequence, to patients characterized by specific serum levels and height measurements. Another method details the administration of IGF-I, either alone or in combination with growth hormone, to achieve effective treatment outcomes.

Career Highlights

Lena M Carlsson is currently associated with Genentech, Inc., where she continues her research and development efforts. Her innovative approaches have the potential to transform treatment protocols for patients with growth hormone deficiencies.

Collaborations

Lena has collaborated with notable colleagues in her field, including Kenneth M Attie and Neil Gesundheit. These partnerships have further enhanced her research and contributed to the advancement of growth hormone therapies.

Conclusion

Lena M Carlsson's work in the field of growth hormone research exemplifies the impact of innovation in medicine. Her patents and collaborations highlight her commitment to improving patient outcomes through scientific advancement.